25 XP   0   0   10

Windtree Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Windtree Therapeutics Inc together

PenkeI guess you are interested in Windtree Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Windtree Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Windtree Therapeutics Inc

I send you an email if I find something interesting about Windtree Therapeutics Inc.

Quick analysis of Windtree Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Windtree Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.82
Expected worth in 1 year
$-0.27
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-1.08
Return On Investment
-305.7%

For what price can you sell your share?

Current Price per Share
$0.35
Expected price per share
$0.34 - $0.41
How sure are you?
50%

1. Valuation of Windtree Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.35

Intrinsic Value Per Share

$-11.29 - $10.49

Total Value Per Share

$-10.48 - $11.30

2. Growth of Windtree Therapeutics Inc (5 min.)




Is Windtree Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$7.4m$28.3m-$19.2m-213.4%

How much money is Windtree Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.3m-$10.3m$4m64.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Windtree Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#720 / 1031

Most Revenue
#822 / 1031

Most Profit
#502 / 1031

Most Efficient
#274 / 1031

What can you expect buying and holding a share of Windtree Therapeutics Inc? (5 min.)

Welcome investor! Windtree Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Windtree Therapeutics Inc.

What can you expect buying and holding a share of Windtree Therapeutics Inc?

First you should know what it really means to hold a share of Windtree Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Windtree Therapeutics Inc is $0.354. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Windtree Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Windtree Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.82. Based on the TTM, the Book Value Change Per Share is $-0.27 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.89 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Windtree Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-136.2%-0.52-148.1%-0.93-261.6%-1.01-284.8%-1.01-286.0%
Usd Book Value Change Per Share-0.45-126.8%-0.27-76.4%-0.89-252.0%0.2159.7%0.011.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.45-126.8%-0.27-76.4%-0.89-252.0%0.2159.7%0.011.5%
Usd Price Per Share0.95-1.84-0.87-3.03-2.40-
Price to Earnings Ratio-0.49--0.95--0.34--1.03--0.68-
Price-to-Total Gains Ratio-2.11--3.79--0.42--22.69--2.43-
Price to Book Ratio1.16-2.21-0.42-0.90-0.22-
Price-to-Total Gains Ratio-2.11--3.79--0.42--22.69--2.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.354
Number of shares2824
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.270.21
Usd Total Gains Per Share-0.270.21
Gains per Quarter (2824 shares)-764.06596.99
Gains per Year (2824 shares)-3,056.232,387.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3056-3066023882378
20-6112-6122047764766
30-9169-9178071647154
40-12225-12234095529542
50-15281-1529001194011930
60-18337-1834601432814318
70-21394-2140201671616706
80-24450-2445801910419094
90-27506-2751402149221482
100-30562-3057002388023870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.0112.00.00.9%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%33.080.00.029.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0113.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%33.080.00.029.2%

Fundamentals of Windtree Therapeutics Inc

About Windtree Therapeutics Inc

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company's lead development programs include istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as in Phase 2a clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase 2b clinical trial to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant, which is in Phase 2a clinical trial for the treatment of lung injury resulting from COVID-19; Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activator, which is in preclinical trial for the treatment of chronic and acute heart failure. Windtree Therapeutics, Inc. has a scientific collaboration with Chang Gung University for cardiovascular diseases of SERCA2a; collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. The company was founded in 1992 and is headquartered in Warrington, Pennsylvania.

Fundamental data was last updated by Penke on 2024-03-22 07:42:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Windtree Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Windtree Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Windtree Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-501.1%+501.1%
5Y-501.1%10Y-4,661.4%+4,160.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y-501.1%-452.4%-48.7%
10Y-4,661.4%-589.0%-4,072.4%
1.1.2. Return on Assets

Shows how efficient Windtree Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • -12.3% Return on Assets means that Windtree Therapeutics Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Windtree Therapeutics Inc:

  • The MRQ is -12.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.3%TTM-16.8%+4.5%
TTM-16.8%YOY-17.4%+0.6%
TTM-16.8%5Y-12.8%-4.0%
5Y-12.8%10Y-29.8%+17.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.3%-12.5%+0.2%
TTM-16.8%-12.2%-4.6%
YOY-17.4%-11.2%-6.2%
5Y-12.8%-13.3%+0.5%
10Y-29.8%-14.6%-15.2%
1.1.3. Return on Equity

Shows how efficient Windtree Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • -59.1% Return on Equity means Windtree Therapeutics Inc generated $-0.59 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Windtree Therapeutics Inc:

  • The MRQ is -59.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -69.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.1%TTM-69.5%+10.4%
TTM-69.5%YOY-40.8%-28.8%
TTM-69.5%5Y-31.9%-37.6%
5Y-31.9%10Y-30.0%-1.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.1%-16.0%-43.1%
TTM-69.5%-15.8%-53.7%
YOY-40.8%-13.9%-26.9%
5Y-31.9%-18.2%-13.7%
10Y-30.0%-19.1%-10.9%

1.2. Operating Efficiency of Windtree Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Windtree Therapeutics Inc is operating .

  • Measures how much profit Windtree Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Windtree Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-470.9%+470.9%
5Y-470.9%10Y-3,910.5%+3,439.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y-470.9%-459.9%-11.0%
10Y-3,910.5%-596.9%-3,313.6%
1.2.2. Operating Ratio

Measures how efficient Windtree Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Windtree Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y5.820-5.820
5Y5.82010Y66.332-60.512
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y5.8205.554+0.266
10Y66.3327.396+58.936

1.3. Liquidity of Windtree Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Windtree Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.40 means the company has $2.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Windtree Therapeutics Inc:

  • The MRQ is 2.402. The company is able to pay all its short-term debts. +1
  • The TTM is 2.701. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.402TTM2.701-0.299
TTM2.701YOY3.310-0.609
TTM2.7015Y3.004-0.302
5Y3.00410Y2.843+0.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4023.987-1.585
TTM2.7014.440-1.739
YOY3.3105.569-2.259
5Y3.0046.158-3.154
10Y2.8436.492-3.649
1.3.2. Quick Ratio

Measures if Windtree Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.99 means the company can pay off $1.99 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Windtree Therapeutics Inc:

  • The MRQ is 1.986. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.263. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.986TTM2.263-0.278
TTM2.263YOY3.020-0.757
TTM2.2635Y2.831-0.568
5Y2.83110Y2.715+0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9863.653-1.667
TTM2.2634.158-1.895
YOY3.0205.515-2.495
5Y2.8316.012-3.181
10Y2.7156.206-3.491

1.4. Solvency of Windtree Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Windtree Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Windtree Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.79 means that Windtree Therapeutics Inc assets are financed with 79.2% credit (debt) and the remaining percentage (100% - 79.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Windtree Therapeutics Inc:

  • The MRQ is 0.792. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.761. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.792TTM0.761+0.032
TTM0.761YOY0.547+0.213
TTM0.7615Y0.498+0.263
5Y0.49810Y2.309-1.811
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7920.336+0.456
TTM0.7610.330+0.431
YOY0.5470.267+0.280
5Y0.4980.367+0.131
10Y2.3090.378+1.931
1.4.2. Debt to Equity Ratio

Measures if Windtree Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 381.8% means that company has $3.82 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Windtree Therapeutics Inc:

  • The MRQ is 3.818. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.278. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.818TTM3.278+0.540
TTM3.278YOY1.295+1.983
TTM3.2785Y1.309+1.969
5Y1.30910Y1.020+0.289
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8180.376+3.442
TTM3.2780.398+2.880
YOY1.2950.334+0.961
5Y1.3090.431+0.878
10Y1.0200.476+0.544

2. Market Valuation of Windtree Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Windtree Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Windtree Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.49 means the investor is paying $-0.49 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Windtree Therapeutics Inc:

  • The EOD is -0.184. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.492. Based on the earnings, the company is expensive. -2
  • The TTM is -0.952. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.184MRQ-0.492+0.308
MRQ-0.492TTM-0.952+0.460
TTM-0.952YOY-0.342-0.610
TTM-0.9525Y-1.031+0.079
5Y-1.03110Y-0.681-0.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.184-2.697+2.513
MRQ-0.492-2.422+1.930
TTM-0.952-2.709+1.757
YOY-0.342-4.116+3.774
5Y-1.031-6.257+5.226
10Y-0.681-6.478+5.797
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Windtree Therapeutics Inc:

  • The EOD is -0.210. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.563. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.511. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.210MRQ-0.563+0.353
MRQ-0.563TTM-1.511+0.949
TTM-1.511YOY-0.710-0.801
TTM-1.5115Y-1.561+0.050
5Y-1.56110Y-1.118-0.443
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.210-3.344+3.134
MRQ-0.563-2.939+2.376
TTM-1.511-3.486+1.975
YOY-0.710-5.592+4.882
5Y-1.561-8.464+6.903
10Y-1.118-8.872+7.754
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Windtree Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.16 means the investor is paying $1.16 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Windtree Therapeutics Inc:

  • The EOD is 0.434. Based on the equity, the company is cheap. +2
  • The MRQ is 1.164. Based on the equity, the company is underpriced. +1
  • The TTM is 2.207. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.434MRQ1.164-0.729
MRQ1.164TTM2.207-1.043
TTM2.207YOY0.421+1.786
TTM2.2075Y0.903+1.304
5Y0.90310Y0.220+0.683
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4342.198-1.764
MRQ1.1642.042-0.878
TTM2.2072.121+0.086
YOY0.4212.907-2.486
5Y0.9033.682-2.779
10Y0.2204.114-3.894
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Windtree Therapeutics Inc.

3.1. Institutions holding Windtree Therapeutics Inc

Institutions are holding 12.916% of the shares of Windtree Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Alyeska Investment Group, L.P.1.60570.00091365181365180
2023-12-31Vanguard Group Inc0.489804164000
2023-12-31Virtu Financial LLC0.45730.002238877388770
2023-12-31Geode Capital Management, LLC0.16701419700
2023-12-31UBS Group AG0.0060510-5401-91.372
2023-12-31Wells Fargo & Co0.000403226.6667
2023-12-31U.S. Bancorp00300
2023-12-31Morgan Stanley - Brokerage Accounts002-1-33.3333
2023-12-31Advisor Group Holdings, Inc.00100
2023-12-31IFP Advisors, LLC00100
2023-12-31Tower Research Capital LLC000-9668-100
2023-09-30Citadel Advisors Llc000-21722-100
2023-09-30TWO SIGMA SECURITIES, LLC000-16871-100
Total 2.72620.0031231781+121734+52.5%

3.2. Funds holding Windtree Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.489804164000
2024-01-31Fidelity Extended Market Index0.160101361000
2024-02-29State St US Extended Mkt Indx NL Cl C0.0045038600
2023-12-31SSgA U.S. Extended Market Index Class I0.0045038600
2024-01-31Fidelity Nasdaq Composite Index0.0045038100
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0038032500
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0031026100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0029024300
2023-12-31Northern Trust Extended Eq Market Idx0.0029024300
2023-12-31NT Quality SCC US Fund - L0.00220.000118500
2023-12-31NT Quality Small Cap Core0.00220.000118500
2024-01-31Fidelity Series Total Market Index0.002016800
2023-12-31SSgA U.S. Total Market Index Strategy0.00130111-3-2.6316
2024-01-31Spartan Extended Market Index Pool E0.000403800
2023-12-31Northern Trust Wilshire 50000.000201400
2023-12-31NT US Market Cap Idx Fd - L0.000201400
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000101100
Total 0.68470.000258201-30.0%

3.3. Insider Transactions

Insiders are holding 4.653% of the shares of Windtree Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-26Craig FraserBUY25000.9
2023-04-25Craig FraserBUY13151.89

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Windtree Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.449-0.271-40%-0.892+99%0.211-312%0.005-8303%
Book Value Per Share--0.8150.984-17%2.335-65%4.836-83%2.284-64%
Current Ratio--2.4022.701-11%3.310-27%3.004-20%2.843-16%
Debt To Asset Ratio--0.7920.761+4%0.547+45%0.498+59%2.309-66%
Debt To Equity Ratio--3.8183.278+16%1.295+195%1.309+192%1.020+274%
Dividend Per Share----0%-0%-0%-0%
Eps---0.482-0.524+9%-0.926+92%-1.008+109%-1.013+110%
Free Cash Flow Per Share---0.421-0.361-14%-0.486+15%-0.543+29%-0.688+63%
Free Cash Flow To Equity Per Share---0.447-0.029-93%-0.405-9%0.321-239%0.076-685%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--10.485--------
Intrinsic Value_10Y_min---11.294--------
Intrinsic Value_1Y_max---1.478--------
Intrinsic Value_1Y_min---2.494--------
Intrinsic Value_3Y_max---2.514--------
Intrinsic Value_3Y_min---6.358--------
Intrinsic Value_5Y_max---1.226--------
Intrinsic Value_5Y_min---8.948--------
Market Cap3250077.540-168%8709106.08616889845.047-48%14992306.472-42%32246065.074-73%24242281.683-64%
Net Profit Margin----0%-0%-5.0110%-46.6140%
Operating Margin----0%-0%-4.7090%-39.1050%
Operating Ratio----0%-0%5.820-100%66.332-100%
Pb Ratio0.434-168%1.1642.207-47%0.421+176%0.903+29%0.220+429%
Pe Ratio-0.184+63%-0.492-0.952+93%-0.342-30%-1.031+109%-0.681+38%
Price Per Share0.354-168%0.9491.840-48%0.866+9%3.030-69%2.399-60%
Price To Free Cash Flow Ratio-0.210+63%-0.563-1.511+169%-0.710+26%-1.561+177%-1.118+99%
Price To Total Gains Ratio-0.789+63%-2.114-3.794+79%-0.424-80%-22.690+973%-2.429+15%
Quick Ratio--1.9862.263-12%3.020-34%2.831-30%2.715-27%
Return On Assets---0.123-0.168+37%-0.174+42%-0.128+5%-0.298+143%
Return On Equity---0.591-0.695+18%-0.408-31%-0.319-46%-0.300-49%
Total Gains Per Share---0.449-0.271-40%-0.892+99%0.211-312%0.005-8303%
Usd Book Value--7484000.0009032250.000-17%28306750.000-74%48697900.000-85%23115550.000-68%
Usd Book Value Change Per Share---0.449-0.271-40%-0.892+99%0.211-312%0.005-8303%
Usd Book Value Per Share--0.8150.984-17%2.335-65%4.836-83%2.284-64%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.482-0.524+9%-0.926+92%-1.008+109%-1.013+110%
Usd Free Cash Flow---3869000.000-3316250.000-14%-5297500.000+37%-5366900.000+39%-6512000.000+68%
Usd Free Cash Flow Per Share---0.421-0.361-14%-0.486+15%-0.543+29%-0.688+63%
Usd Free Cash Flow To Equity Per Share---0.447-0.029-93%-0.405-9%0.321-239%0.076-685%
Usd Market Cap3250077.540-168%8709106.08616889845.047-48%14992306.472-42%32246065.074-73%24242281.683-64%
Usd Price Per Share0.354-168%0.9491.840-48%0.866+9%3.030-69%2.399-60%
Usd Profit---4425000.000-6328250.000+43%-10396000.000+135%-9694450.000+119%-9182275.000+108%
Usd Revenue----0%-0%38300.000-100%239225.000-100%
Usd Total Gains Per Share---0.449-0.271-40%-0.892+99%0.211-312%0.005-8303%
 EOD+3 -5MRQTTM+8 -21YOY+13 -165Y+10 -2110Y+11 -20

4.2. Fundamental Score

Let's check the fundamental score of Windtree Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.184
Price to Book Ratio (EOD)Between0-10.434
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.986
Current Ratio (MRQ)Greater than12.402
Debt to Asset Ratio (MRQ)Less than10.792
Debt to Equity Ratio (MRQ)Less than13.818
Return on Equity (MRQ)Greater than0.15-0.591
Return on Assets (MRQ)Greater than0.05-0.123
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Windtree Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.365
Ma 20Greater thanMa 500.370
Ma 50Greater thanMa 1000.384
Ma 100Greater thanMa 2000.604
OpenGreater thanClose0.360
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets36,057
Total Liabilities28,573
Total Stockholder Equity7,484
 As reported
Total Liabilities 28,573
Total Stockholder Equity+ 7,484
Total Assets = 36,057

Assets

Total Assets36,057
Total Current Assets8,908
Long-term Assets27,149
Total Current Assets
Cash And Cash Equivalents 7,365
Other Current Assets 1,543
Total Current Assets  (as reported)8,908
Total Current Assets  (calculated)8,908
+/-0
Long-term Assets
Property Plant Equipment 1,749
Intangible Assets 25,250
Long-term Assets Other 150
Long-term Assets  (as reported)27,149
Long-term Assets  (calculated)27,149
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,709
Long-term Liabilities24,864
Total Stockholder Equity7,484
Total Current Liabilities
Short-term Debt 906
Short Long Term Debt 467
Accounts payable 944
Other Current Liabilities 2,326
Total Current Liabilities  (as reported)3,709
Total Current Liabilities  (calculated)4,643
+/- 934
Long-term Liabilities
Capital Lease Obligations 1,690
Long-term Liabilities Other 18,800
Long-term Liabilities  (as reported)24,864
Long-term Liabilities  (calculated)20,490
+/- 4,374
Total Stockholder Equity
Common Stock5
Retained Earnings -839,669
Other Stockholders Equity 847,148
Total Stockholder Equity (as reported)7,484
Total Stockholder Equity (calculated)7,484
+/-0
Other
Capital Stock5
Cash and Short Term Investments 7,365
Common Stock Shares Outstanding 5,148
Current Deferred Revenue-467
Liabilities and Stockholders Equity 36,057
Net Debt -5,208
Net Invested Capital 7,951
Net Working Capital 5,199
Property Plant and Equipment Gross 1,749
Short Long Term Debt Total 2,157



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-31
> Total Assets 
100
800
0
4,000
3,600
3,200
2,600
1,900
2,300
1,800
2,900
11,700
9,700
7,200
6,000
5,100
4,600
3,200
4,200
4,632
24,753
23,255
22,419
19,700
19,717
14,675
12,168
20,065
20,251
16,478
13,168
21,062
16,140
37,708
38,981
32,715
27,213
45,712
39,591
37,637
56,776
48,026
55,411
56,008
43,461
32,437
24,821
34,400
27,697
49,074
42,348
62,744
52,673
44,619
39,649
32,889
26,271
29,940
23,809
21,403
29,509
28,403
19,298
14,537
31,680
25,248
18,723
13,324
57,738
49,181
39,752
29,943
29,162
33,907
23,631
89,317
79,498
69,474
58,309
47,499
38,122
28,200
52,732
44,377
34,710
24,998
16,434
9,699
11,707
5,825
4,657
3,300
3,347
1,979
1,943
119,398
119,398
105,245
100,632
118,975
118,975
128,323
118,531
112,885
135,893
90,865
84,825
74,789
67,108
51,813
48,098
37,954
35,185
40,575
36,057
36,05740,57535,18537,95448,09851,81367,10874,78984,82590,865135,893112,885118,531128,323118,975118,975100,632105,245119,398119,3981,9431,9793,3473,3004,6575,82511,7079,69916,43424,99834,71044,37752,73228,20038,12247,49958,30969,47479,49889,31723,63133,90729,16229,94339,75249,18157,73813,32418,72325,24831,68014,53719,29828,40329,50921,40323,80929,94026,27132,88939,64944,61952,67362,74442,34849,07427,69734,40024,82132,43743,46156,00855,41148,02656,77637,63739,59145,71227,21332,71538,98137,70816,14021,06213,16816,47820,25120,06512,16814,67519,71719,70022,41923,25524,7534,6324,2003,2004,6005,1006,0007,2009,70011,7002,9001,8002,3001,9002,6003,2003,6004,0000800100
   > Total Current Assets 
0
800
0
4,000
3,600
3,100
2,500
1,800
2,200
1,700
2,500
11,400
9,500
7,000
5,800
4,800
4,200
2,800
3,700
4,188
24,288
22,659
21,186
19,000
19,017
13,999
11,278
18,278
18,742
15,196
11,729
19,517
14,429
35,986
36,801
30,090
24,124
42,580
34,868
33,342
52,566
43,730
51,063
51,468
38,445
27,637
20,001
27,567
20,964
41,532
33,384
53,618
43,987
36,221
31,680
25,417
19,463
23,624
17,955
15,974
24,442
23,703
14,919
10,496
27,952
21,841
15,738
10,631
55,195
46,546
37,357
27,806
26,991
31,907
21,712
87,239
76,817
66,484
55,723
45,559
36,159
26,662
48,727
40,794
31,335
21,948
13,686
7,194
9,508
3,940
3,094
2,200
2,237
1,035
1,039
25,653
25,653
9,883
5,263
23,861
23,861
33,636
24,048
18,118
39,341
32,294
26,367
23,491
16,447
13,162
10,032
7,377
5,222
13,319
8,908
8,90813,3195,2227,37710,03213,16216,44723,49126,36732,29439,34118,11824,04833,63623,86123,8615,2639,88325,65325,6531,0391,0352,2372,2003,0943,9409,5087,19413,68621,94831,33540,79448,72726,66236,15945,55955,72366,48476,81787,23921,71231,90726,99127,80637,35746,54655,19510,63115,73821,84127,95210,49614,91923,70324,44215,97417,95523,62419,46325,41731,68036,22143,98753,61833,38441,53220,96427,56720,00127,63738,44551,46851,06343,73052,56633,34234,86842,58024,12430,09036,80135,98614,42919,51711,72915,19618,74218,27811,27813,99919,01719,00021,18622,65924,2884,1883,7002,8004,2004,8005,8007,0009,50011,4002,5001,7002,2001,8002,5003,1003,6004,00008000
       Cash And Cash Equivalents 
0
500
0
0
100
100
100
200
1,200
500
300
6,300
5,900
3,400
2,700
1,500
1,500
700
1,700
3,547
23,591
11,813
9,566
7,300
7,281
3,772
3,136
3,758
5,515
2,901
3,402
8,538
6,884
31,213
32,607
29,422
23,564
23,527
22,160
29,264
28,957
17,335
41,249
47,010
32,226
26,627
18,893
26,173
18,079
21,495
18,831
36,929
19,050
27,343
26,925
22,744
19,125
23,377
17,683
15,741
24,172
23,320
14,654
10,211
27,663
21,542
15,411
10,189
54,802
46,008
36,064
26,892
26,370
31,253
21,177
86,283
75,942
65,557
54,915
44,711
35,583
26,091
46,308
38,722
29,400
20,330
12,383
5,588
8,022
2,528
1,752
1,800
1,815
638
640
11,187
11,187
6,124
4,437
22,578
22,578
31,515
22,356
16,930
38,490
29,965
24,541
22,348
15,541
11,378
8,436
6,172
4,235
11,467
7,365
7,36511,4674,2356,1728,43611,37815,54122,34824,54129,96538,49016,93022,35631,51522,57822,5784,4376,12411,18711,1876406381,8151,8001,7522,5288,0225,58812,38320,33029,40038,72246,30826,09135,58344,71154,91565,55775,94286,28321,17731,25326,37026,89236,06446,00854,80210,18915,41121,54227,66310,21114,65423,32024,17215,74117,68323,37719,12522,74426,92527,34319,05036,92918,83121,49518,07926,17318,89326,62732,22647,01041,24917,33528,95729,26422,16023,52723,56429,42232,60731,2136,8848,5383,4022,9015,5153,7583,1363,7727,2817,3009,56611,81323,5913,5471,7007001,5001,5002,7003,4005,9006,3003005001,200200100100100005000
       Short-term Investments 
0
0
0
0
0
3,000
2,400
1,500
1,000
1,200
2,200
5,000
3,500
3,500
2,900
2,500
2,500
1,500
1,400
0
0
10,038
10,282
11,600
11,587
9,901
7,990
12,938
11,953
10,692
7,572
10,652
7,286
4,300
3,287
0
0
17,782
10,673
2,744
22,233
24,965
8,444
3,251
4,663
0
0
0
2,000
18,611
13,609
16,078
22,495
6,021
4,534
2,048
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,959
13,959
2,540
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,54013,95913,95900000000000000000000000000000000000000-12,0484,5346,02122,49516,07813,60918,6112,0000004,6633,2518,44424,96522,2332,74410,67317,782003,2874,3007,28610,6527,57210,69211,95312,9387,9909,90111,58711,60010,28210,038001,4001,5002,5002,5002,9003,5003,5005,0002,2001,2001,0001,5002,4003,00000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-600
0
100
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
3
3
2
2
2
3
3
3
3
3
0
0
0
0
0
0
0
0
2,000
2,500
0
0
0
0
272
0
270
383
0
0
0
0
0
0
0
0
0
0
0
0
0
67
100
41
22
78
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000782241100670000000000000383270027200002,5002,0000000000033333222332222222200000001000-6000000000000000000
       Other Current Assets 
0
300
0
0
3,500
3,000
2,400
1,600
1,000
1,200
0
5,100
3,600
3,600
3,100
200
2,700
0
-100
66
122
233
763
149
149
326
200
1,600
1,200
1,600
700
325
257
471
904
665
558
1,269
2,033
1,331
1,373
1,427
1,367
1,204
1,556
1,010
1,108
1,394
885
1,426
944
611
442
357
221
625
338
247
17,683
233
24,172
23,320
265
285
289
299
327
442
393
433
1,165
719
621
618
418
777
702
443
357
821
576
571
1,986
2,072
1,935
1,618
1,303
1,606
1,486
1,412
1,342
422
422
397
399
77,597
507
1,219
826
1,283
1,283
2,121
1,692
1,188
851
2,329
1,826
1,143
906
1,784
1,596
1,205
987
1,852
1,543
1,5431,8529871,2051,5961,7849061,1431,8262,3298511,1881,6922,1211,2831,2838261,21950777,5973993974224221,3421,4121,4861,6061,3031,6181,9352,0721,9865715768213574437027774186186217191,16543339344232729928928526523,32024,17223317,6832473386252213574426119441,4268851,3941,1081,0101,5561,2041,3671,4271,3731,3312,0331,2695586659044712573257001,6001,2001,60020032614914976323312266-10002,7002003,1003,6003,6005,10001,2001,0001,6002,4003,0003,500003000
   > Long-term Assets 
100
0
0
0
100
100
100
100
100
100
400
300
200
200
200
300
400
400
500
444
465
596
1,233
0
700
676
890
1,787
1,509
1,282
1,439
1,545
1,711
1,722
2,180
2,625
3,089
3,132
4,723
4,295
4,210
4,296
4,348
4,540
5,016
4,800
4,820
6,833
6,733
7,542
8,964
9,126
8,686
8,398
7,969
7,472
6,808
6,316
5,854
5,429
5,067
4,700
4,379
4,041
3,728
3,407
2,985
2,693
2,543
2,635
2,395
2,137
2,171
2,000
1,919
2,078
2,681
2,990
2,586
1,940
1,963
1,538
4,005
3,583
3,375
3,050
2,748
2,505
2,199
1,885
1,563
885
1,110
944
904
16,484
93,745
95,362
95,369
94,960
95,114
94,687
94,483
94,767
96,552
58,571
58,458
51,298
50,661
38,651
38,066
30,577
29,963
27,256
27,149
27,14927,25629,96330,57738,06638,65150,66151,29858,45858,57196,55294,76794,48394,68795,11494,96095,36995,36293,74516,4849049441,1108851,5631,8852,1992,5052,7483,0503,3753,5834,0051,5381,9631,9402,5862,9902,6812,0781,9192,0002,1712,1372,3952,6352,5432,6932,9853,4073,7284,0414,3794,7005,0675,4295,8546,3166,8087,4727,9698,3988,6869,1268,9647,5426,7336,8334,8204,8005,0164,5404,3484,2964,2104,2954,7233,1323,0892,6252,1801,7221,7111,5451,4391,2821,5091,78789067670001,233596465444500400400300200200200300400100100100100100100000100
       Property Plant Equipment 
0
0
0
0
100
100
100
100
100
100
100
200
200
200
200
300
300
300
400
426
447
527
1,230
697
697
673
671
822
898
987
1,122
1,231
1,409
1,433
1,905
2,414
2,878
2,922
2,916
4,063
3,990
4,076
4,129
4,322
4,798
4,583
4,604
4,794
4,831
5,618
7,186
7,069
6,766
6,616
6,324
5,965
5,639
5,285
4,960
4,668
4,444
4,116
3,804
3,467
3,159
2,839
2,585
2,293
2,143
2,235
1,995
1,737
1,660
1,493
1,417
1,656
2,007
2,178
1,772
1,637
1,665
1,245
1,186
1,039
1,100
1,048
1,022
1,054
1,018
977
930
885
885
804
764
802
802
2,437
2,443
798
2,188
1,761
1,557
1,841
3,626
3,415
3,302
3,392
2,755
2,381
2,250
2,115
1,976
1,856
1,749
1,7491,8561,9762,1152,2502,3812,7553,3923,3023,4153,6261,8411,5571,7612,1887982,4432,4378028027648048858859309771,0181,0541,0221,0481,1001,0391,1861,2451,6651,6371,7722,1782,0071,6561,4171,4931,6601,7371,9952,2352,1432,2932,5852,8393,1593,4673,8044,1164,4444,6684,9605,2855,6395,9656,3246,6166,7667,0697,1865,6184,8314,7944,6044,5834,7984,3224,1294,0763,9904,0632,9162,9222,8782,4141,9051,4331,4091,2311,1229878988226716736976971,2305274474264003003003002002002002001001001001001001001000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
15,682
4,046
3,592
3,058
2,574
0
0
002,5743,0583,5924,04615,68215,68215,68215,68215,68215,68215,68215,68215,68215,68215,68215,68215,68215,68200000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,090
77,090
77,090
77,090
77,090
77,090
77,090
77,090
77,090
77,090
39,320
39,320
32,070
32,070
32,070
32,070
25,250
25,250
25,250
25,250
25,25025,25025,25025,25032,07032,07032,07032,07039,32039,32077,09077,09077,09077,09077,09077,09077,09077,09077,09077,09000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
-100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
69
3
3
3
3
219
965
611
295
317
314
302
289
275
211
211
210
1,807
232
220
220
219
218
218
217
216
2,039
1,902
1,924
1,778
2,057
1,920
1,782
1,645
1,507
1,169
1,031
894
761
623
584
575
574
569
568
400
400
400
400
400
400
511
507
502
422
674
812
814
303
298
293
2,819
2,544
2,275
2,002
1,726
1,451
1,181
908
633
225
140
140
140
171
171
153
154
154
154
154
154
154
154
154
154
154
154
154
154
0
163
150
0
015016301541541541541541541541541541541541541541531711711401401402256339081,1811,4511,7262,0022,2752,5442,8192932983038148126744225025075114004004004004004005685695745755846237618941,0311,1691,5071,6451,7821,9202,0571,7781,9241,9022,0392162172182182192202202321,80721021121127528930231431729561196521933336918000000000000000-1000000
> Total Liabilities 
2,100
3,400
0
400
400
300
300
300
1,300
1,300
1,400
900
1,100
1,200
900
1,100
1,100
1,100
600
1,524
1,789
1,769
2,068
3,300
3,281
1,567
1,129
2,442
3,753
4,026
5,081
6,301
6,014
6,005
7,352
8,412
9,445
11,612
12,147
16,540
17,292
17,829
17,994
21,170
21,613
21,547
20,778
20,078
18,929
20,663
22,080
23,963
22,375
23,300
23,493
21,956
20,832
18,981
18,185
16,916
16,773
10,354
9,199
8,511
14,814
16,041
13,995
12,060
15,505
13,480
16,701
12,290
19,705
17,091
18,156
30,816
30,691
30,268
29,344
28,300
30,310
31,278
34,842
36,111
39,687
40,217
39,284
38,529
37,467
38,008
42,105
27,300
27,267
30,363
33,276
51,284
51,284
46,975
47,561
44,040
44,040
44,867
42,806
43,333
44,405
34,102
34,646
32,908
32,379
32,616
30,678
27,942
28,156
28,971
28,573
28,57328,97128,15627,94230,67832,61632,37932,90834,64634,10244,40543,33342,80644,86744,04044,04047,56146,97551,28451,28433,27630,36327,26727,30042,10538,00837,46738,52939,28440,21739,68736,11134,84231,27830,31028,30029,34430,26830,69130,81618,15617,09119,70512,29016,70113,48015,50512,06013,99516,04114,8148,5119,19910,35416,77316,91618,18518,98120,83221,95623,49323,30022,37523,96322,08020,66318,92920,07820,77821,54721,61321,17017,99417,82917,29216,54012,14711,6129,4458,4127,3526,0056,0146,3015,0814,0263,7532,4421,1291,5673,2813,3002,0681,7691,7891,5246001,1001,1001,1009001,2001,1009001,4001,3001,30030030030040040003,4002,100
   > Total Current Liabilities 
2,000
2,300
0
300
400
300
300
300
400
1,300
1,500
600
800
900
900
1,100
1,100
1,100
500
1,476
1,745
1,729
2,032
2,400
2,399
1,090
854
1,794
1,520
1,716
2,114
3,202
2,805
2,925
3,950
7,029
8,074
10,022
10,544
8,823
7,090
7,697
7,878
17,608
18,331
17,586
17,289
7,968
7,089
7,942
8,965
10,469
9,329
10,955
11,265
9,866
8,844
17,714
16,943
15,798
15,695
9,332
8,231
7,576
13,823
15,073
13,062
11,147
14,597
12,608
15,864
11,699
13,012
10,348
11,310
11,855
11,135
10,862
9,427
7,829
9,257
9,768
9,786
11,068
14,647
15,055
14,129
13,391
24,836
25,384
29,488
11,800
11,760
15,181
18,110
20,633
20,633
15,535
16,278
7,817
7,817
12,232
6,314
6,131
7,484
4,910
5,143
4,923
4,750
5,334
3,951
2,457
2,763
3,794
3,709
3,7093,7942,7632,4573,9515,3344,7504,9235,1434,9107,4846,1316,31412,2327,8177,81716,27815,53520,63320,63318,11015,18111,76011,80029,48825,38424,83613,39114,12915,05514,64711,0689,7869,7689,2577,8299,42710,86211,13511,85511,31010,34813,01211,69915,86412,60814,59711,14713,06215,07313,8237,5768,2319,33215,69515,79816,94317,7148,8449,86611,26510,9559,32910,4698,9657,9427,0897,96817,28917,58618,33117,6087,8787,6977,0908,82310,54410,0228,0747,0293,9502,9252,8053,2022,1141,7161,5201,7948541,0902,3992,4002,0321,7291,7451,4765001,1001,1001,1009009008006001,5001,30040030030030040030002,3002,000
       Short-term Debt 
1,600
1,700
0
100
100
100
0
100
100
1,200
1,000
0
0
0
0
0
0
0
0
0
15
15
15
17
17
18
18
44
45
46
114
189
238
232
312
383
447
559
6,326
0
899
931
1,009
1,568
10,163
10,383
10,422
2,015
1,970
1,758
2,146
2,625
2,794
0
2,999
2,442
1,810
10,291
11,065
11,058
11,017
4,331
196
136
122
93
74
68
67
67
68
69
70
71
72
73
74
75
76
62
42
21
497
223
0
0
0
25,000
12,500
12,500
15,100
15,000
2,500
2,500
5,249
7,974
7,974
8,703
8,563
161
911
6,365
1,309
1,157
2,801
1,511
1,012
822
472
1,439
1,045
656
389
1,099
906
9061,0993896561,0451,4394728221,0121,5112,8011,1571,3096,3659111618,5638,7037,9747,9745,2492,5002,50015,00015,10012,50012,50025,00000022349721426276757473727170696867676874931221361964,33111,01711,05811,06510,2911,8102,4422,99902,7942,6252,1461,7581,9702,01510,42210,38310,1631,5681,00993189906,326559447383312232238189114464544181817171515150000000001,0001,200100100010010010001,7001,600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,000
16,598
25,000
12,500
15,000
17,500
17,500
0
0
7,469
8,047
7,782
161
0
5,714
704
352
2,409
1,175
734
294
0
1,007
629
252
0
700
467
46770002526291,00702947341,1752,4093527045,71401617,7828,0477,4690017,50017,50015,00012,50025,00016,59825,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
100
200
0
100
100
100
100
100
200
100
200
600
800
900
900
1,100
1,100
1,100
500
425
694
678
981
2,382
2,382
1,072
836
1,750
1,475
1,670
2,000
3,013
2,567
2,693
3,638
4,210
4,362
4,652
4,218
8,000
6,191
6,766
6,869
7,540
8,168
7,203
6,867
5,953
5,119
6,184
6,819
758
1,927
3,001
2,429
2,111
1,881
1,850
1,559
1,294
1,147
1,235
1,580
1,685
1,873
1,986
1,386
1,111
1,339
1,335
208
1,166
1,825
1,919
1,489
1,433
2,578
1,507
1,403
350
702
2,314
2,457
3,263
5,512
7,713
5,237
1,813
2,312
2,846
3,770
7,252
3,048
4,258
4,519
25,536
3,420
724
607
4,934
1,708
1,223
726
1,161
939
288
582
693
724
1,072
410
249
753
964
944
9449647532494101,0727246935822889391,1617261,2231,7084,9346077243,42025,5364,5194,2583,0487,2523,7702,8462,3121,8135,2377,7135,5123,2632,4572,3147023501,4031,5072,5781,4331,4891,9191,8251,1662081,3351,3391,1111,3861,9861,8731,6851,5801,2351,1471,2941,5591,8501,8812,1112,4293,0011,9277586,8196,1845,1195,9536,8677,2038,1687,5406,8696,7666,1918,0004,2184,6524,3624,2103,6382,6932,5673,0132,0001,6701,4751,7508361,0722,3822,3829816786944255001,1001,1001,1009009008006002001002001001001001001000200100
       Other Current Liabilities 
300
400
0
100
200
100
200
100
100
-200
300
0
0
0
0
0
0
0
0
1,051
1,036
1,036
1,036
0
-17
-18
-258,000
-44
-45
-46
-14
11
-38
-32
88
2,436
3,265
4,811
-269
-125,177
-73
-49
-29
8,500
18,331
17,586
17,289
7,968
7,089
7,942
8,965
7,086
4,608
7,954
5,837
5,313
5,153
1,320
4,319
3,446
3,531
3,766
2,508
2,469
8,328
10,021
8,599
6,996
10,304
8,614
11,923
6,305
6,143
3,619
4,678
10,210
8,398
9,175
7,853
7,374
1,289
820
7,329
7,805
9,135
7,342
8,892
11,578
10,024
10,038
9,548
4,508
7,828
7,692
7,839
2,774
9,041
6,108
7,108
23,124
5,198
4,644
4,279
3,813
3,744
3,111
3,549
3,408
3,554
2,823
2,496
1,552
1,621
2,431
2,326
2,3262,4311,6211,5522,4962,8233,5543,4083,5493,1113,7443,8134,2794,6445,19823,1247,1086,1089,0412,7747,8397,6927,8284,5089,54810,03810,02411,5788,8927,3429,1357,8057,3298201,2897,3747,8539,1758,39810,2104,6783,6196,1436,30511,9238,61410,3046,9968,59910,0218,3282,4692,5083,7663,5313,4464,3191,3205,1535,3135,8377,9544,6087,0868,9657,9427,0897,96817,28917,58618,3318,500-29-49-73-125,177-2694,8113,2652,43688-32-3811-14-46-45-44-258,000-18-1701,0361,0361,0361,05100000000300-2001001002001002001000400300
   > Long-term Liabilities 
100
1,100
0
100
0
0
0
0
900
0
-100
300
300
300
0
0
0
0
100
48
44
40
36
0
882
477
275
648
2,233
2,310
2,967
3,099
3,209
3,080
3,402
1,383
1,371
1,590
1,603
7,717
10,202
10,132
10,116
3,562
3,282
3,961
3,489
12,110
11,840
12,721
13,115
13,494
13,046
12,345
12,228
12,090
11,988
1,267
1,242
1,118
1,078
1,022
968
935
991
968
933
913
908
872
837
591
6,693
6,743
6,846
18,961
19,556
19,406
19,917
20,471
21,053
21,510
25,056
25,043
25,040
25,162
25,155
25,138
12,631
12,624
12,617
15,507
15,507
15,182
15,166
15,000
30,651
31,440
31,283
15,821
36,223
32,635
36,492
37,202
36,921
29,192
29,503
27,985
27,629
27,282
26,727
25,485
25,393
25,177
24,864
24,86425,17725,39325,48526,72727,28227,62927,98529,50329,19236,92137,20236,49232,63536,22315,82131,28331,44030,65115,00015,16615,18215,50715,50712,61712,62412,63125,13825,15525,16225,04025,04325,05621,51021,05320,47119,91719,40619,55618,9616,8466,7436,6935918378729089139339689919359681,0221,0781,1181,2421,26711,98812,09012,22812,34513,04613,49413,11512,72111,84012,1103,4893,9613,2823,56210,11610,13210,2027,7171,6031,5901,3711,3833,4023,0803,2093,0992,9672,3102,2336482754778820364044481000000300300300-1000900000010001,100100
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260
242
224
205
186
167
148
6,212
6,310
6,415
18,423
18,842
19,292
19,775
20,302
20,857
21,451
25,000
25,000
25,000
0
0
25,000
12,500
0
0
0
0
0
0
0
15,000
15,000
15,000
19,608
4,551
0
0
2,423
0
0
0
0
0
0
0
0
0
0
0
000000000002,423004,55119,60815,00015,00015,000000000012,50025,0000025,00025,00025,00021,45120,85720,30219,77519,29218,84218,4236,4156,3106,21214816718620522424226000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
851
653
456
258
615
2,212
2,301
1,641
1,393
1,213
1,032
852
672
538
403
269
134
73
49
29
239
239
679
622
516
516
966
895
2,003
881
872
866
2,498
2,581
713
696
690
673
657
640
634
713
708
691
689
703
686
670
443
481
433
431
538
714
114
142
169
196
59
56
43
40
162
155
138
131
124
117
507
296
182
166
15,651
15,419
15,370
15,330
15,821
15,759
17,129
18,770
19,578
19,483
11,874
12,307
10,914
10,685
10,443
9,995
0
8,881
8,780
0
08,7808,88109,99510,44310,68510,91412,30711,87419,48319,57818,77017,12915,75915,82115,33015,37015,41915,651166182296507117124131138155162404356591961691421147145384314334814436706867036896917087136346406576736906967132,5812,4988668728812,0038959665165166226792392392949731342694035386728521,0321,2131,3931,6412,3012,21261525845665385100000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
407
203
0
0
0
0
0
0
15,821
0
16,129
16,370
16,778
0
8,674
0
0
0
0
0
0
0
0
0
0000000008,674016,77816,37016,129015,8210000002034070000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-2,000
-2,600
0
3,600
3,200
2,900
2,300
1,600
1,000
500
1,500
8,800
6,600
6,000
5,100
3,500
3,500
2,100
3,600
3,108
22,964
21,486
20,351
16,436
16,436
13,108
11,039
17,623
16,498
12,452
8,087
14,761
10,126
31,703
31,629
24,303
17,768
34,100
27,444
21,097
39,484
30,197
37,417
34,838
21,848
10,890
4,043
14,322
8,768
28,411
20,268
38,781
30,298
21,319
16,156
10,933
5,439
10,959
5,624
4,487
12,736
18,049
10,099
6,026
16,866
9,207
4,728
1,264
42,233
35,701
23,051
17,653
9,457
16,816
5,475
58,501
48,807
39,206
28,965
19,199
7,812
-3,078
17,890
8,266
-4,977
-15,219
-22,850
-28,830
-25,760
-32,183
-37,448
-23,920
-23,920
-28,384
-31,333
68,114
68,114
58,270
53,071
74,935
74,935
83,456
75,725
69,552
91,488
56,763
50,179
41,881
34,729
19,197
17,420
10,012
7,029
11,604
7,484
7,48411,6047,02910,01217,42019,19734,72941,88150,17956,76391,48869,55275,72583,45674,93574,93553,07158,27068,11468,114-31,333-28,384-23,920-23,920-37,448-32,183-25,760-28,830-22,850-15,219-4,9778,26617,890-3,0787,81219,19928,96539,20648,80758,5015,47516,8169,45717,65323,05135,70142,2331,2644,7289,20716,8666,02610,09918,04912,7364,4875,62410,9595,43910,93316,15621,31930,29838,78120,26828,4118,76814,3224,04310,89021,84834,83837,41730,19739,48421,09727,44434,10017,76824,30331,62931,70310,12614,7618,08712,45216,49817,62311,03913,10816,43616,43620,35121,48622,9643,1083,6002,1003,5003,5005,1006,0006,6008,8001,5005001,0001,6002,3002,9003,2003,6000-2,600-2,000
   Common Stock
0
0
0
0
0
10,700
10,800
10,900
10,700
10,700
10,700
0
0
0
0
0
-1,700
-2,000
0
10
21
21
21
21
21
21
21
26
26
26
26
33
33
39
42
43
44
47
47
49
54
54
57
61
61
63
63
70
71
85
85
97
97
97
100
102
104
120
122
127
154
194
200
14
24
24
24
25
43
43
44
44
44
55
55
85
85
85
85
86
86
86
112
8
8
8
8
9
10
11
16
3
3
4
4
32
32
32
32
41
41
17
17
17
26
27
27
28
28
29
33
0
1
5
5
5510332928282727261717174141323232324433161110988881128686868585858555554444444343252424241420019415412712212010410210097979785857170636361615754544947474443423933332626262621212121212121100-2,000-1,7000000010,70010,70010,70010,90010,80010,70000000
   Retained Earnings Total Equity000000000-764,038-726,649-717,688-710,234-701,214-691,656-685,122-677,747-670,621-664,184-657,647-648,605-644,678-641,626-637,114-639,587-634,144-627,392-618,668-612,066-603,703-593,079-579,178-569,069-547,513-536,187-524,008-513,373-502,049-491,426-479,950-468,221-455,998-447,371-434,735-427,920-414,574-407,436-397,420-393,119-388,36800000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-400
-400
-400
0
0
-1,300
0
0
0
0
-200
-200
600
0
-37
-37
-192
-23
200
-274
-471
-20
-192
-259
-12
93
82
18
117
47
-2
0
-595
-524
-464
-411
-364
-293
-232
-175
-115
-58
28,600
28,600
11
20
42
91
7
10
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-9,600
-9,600
0
0
-10,300
-10,300
0
0
-11,100
-11,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001240000000000000000-11,100-11,10000-10,300-10,30000-9,600-9,60000000000000000011079142201128,60028,600-58-115-175-232-293-364-411-464-524-5950-247117188293-12-259-192-20-471-274200-23-192-37-370600-200-2000000-1,30000-400-400-40000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400,605
400,877
401,713
452,680
453,286
453,981
455,398
459,838
475,813
476,695
541,420
543,202
544,224
545,307
546,175
546,967
547,403
589,901
590,490
591,148
591,530
592,262
592,883
604,676
605,004
605,177
616,245
616,611
619,344
620,322
728,783
730,162
731,901
733,840
763,070
764,786
787,707
788,996
790,277
821,165
823,828
0
0
0
0
0
0
0
0
0
000000000823,828821,165790,277788,996787,707764,786763,070733,840731,901730,162728,783620,322619,344616,611616,245605,177605,004604,676592,883592,262591,530591,148590,490589,901547,403546,967546,175545,307544,224543,202541,420476,695475,813459,838455,398453,981453,286452,680401,713400,877400,60500000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,157-3,117-3,054-3,054-3,054-3,054-3,054-3,054-3,054-3,000-2,722-1,289-1,289-239-239-239-239-239-239-239-239-213-213-213-213-250-25000000000000000000000
   Other Stockholders Equity 
0
2,900
0
10,400
10,400
200
300
200
0
0
1,300
21,500
21,500
29,500
29,700
31,600
31,600
32,900
33,200
33,744
57,564
59,486
60,251
0
60,236
61,908
61,339
72,523
74,998
75,052
74,987
87,224
87,158
113,479
119,691
121,120
123,454
149,275
150,930
164,573
192,218
192,710
210,262
236,974
239,722
243,397
244,491
233,950
265,305
295,307
296,502
326,945
328,127
329,447
334,917
338,239
341,744
355,156
357,010
362,009
377,519
389,104
380,615
382,467
397,134
397,551
397,823
398,659
449,626
450,232
450,927
461,944
456,784
472,759
473,641
548,666
540,148
541,170
542,253
554,221
543,913
544,349
586,847
587,436
588,094
588,476
589,208
589,829
601,622
601,950
602,123
0
613,191
616,290
617,268
0
725,729
728,847
730,786
0
760,016
784,653
785,942
787,223
818,111
820,774
822,403
827,177
828,152
829,952
832,227
834,544
835,671
846,843
847,148
847,148846,843835,671834,544832,227829,952828,152827,177822,403820,774818,111787,223785,942784,653760,0160730,786728,847725,7290617,268616,290613,1910602,123601,950601,622589,829589,208588,476588,094587,436586,847544,349543,913554,221542,253541,170540,148548,666473,641472,759456,784461,944450,927450,232449,626398,659397,823397,551397,134382,467380,615389,104377,519362,009357,010355,156341,744338,239334,917329,447328,127326,945296,502295,307265,305233,950244,491243,397239,722236,974210,262192,710192,218164,573150,930149,275123,454121,120119,691113,47987,15887,22474,98775,05274,99872,52361,33961,90860,236060,25159,48657,56433,74433,20032,90031,60031,60029,70029,50021,50021,5001,3000020030020010,40010,40002,9000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-16,038
Operating Income-16,038-16,038
 
Operating Expense (+$)
Research Development6,504
Selling General Administrative9,534
Selling And Marketing Expenses-
Operating Expense16,03816,038
 
Net Interest Income (+$)
Interest Income316
Interest Expense-51
Other Finance Cost-0
Net Interest Income265
 
Pretax Income (+$)
Operating Income-16,038
Net Interest Income265
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-26,196-5,615
EBIT - interestExpense = -51
-24,829
-24,778
Interest Expense51
Earnings Before Interest and Taxes (EBIT)--26,145
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-26,196
Tax Provision--
Net Income From Continuing Ops-24,829-26,196
Net Income-24,829
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-10,423-265
 

Technical Analysis of Windtree Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Windtree Therapeutics Inc. The general trend of Windtree Therapeutics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Windtree Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Windtree Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.41 < 0.41 < 0.41.

The bearish price targets are: 0.34 > 0.34 > 0.34.

Tweet this
Windtree Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Windtree Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Windtree Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Windtree Therapeutics Inc. The current macd is -0.01186709.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Windtree Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Windtree Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Windtree Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Windtree Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartWindtree Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Windtree Therapeutics Inc. The current adx is 23.48.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Windtree Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Windtree Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Windtree Therapeutics Inc. The current sar is 0.38764634.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Windtree Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Windtree Therapeutics Inc. The current rsi is 43.37. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Windtree Therapeutics Inc Daily Relative Strength Index (RSI) ChartWindtree Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Windtree Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Windtree Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Windtree Therapeutics Inc Daily Stochastic Oscillator ChartWindtree Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Windtree Therapeutics Inc. The current cci is -54.72759169.

Windtree Therapeutics Inc Daily Commodity Channel Index (CCI) ChartWindtree Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Windtree Therapeutics Inc. The current cmo is -9.94743048.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Windtree Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartWindtree Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Windtree Therapeutics Inc. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Windtree Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Windtree Therapeutics Inc Daily Williams %R ChartWindtree Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Windtree Therapeutics Inc.

Windtree Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Windtree Therapeutics Inc. The current atr is 0.02523811.

Windtree Therapeutics Inc Daily Average True Range (ATR) ChartWindtree Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Windtree Therapeutics Inc. The current obv is -8,773,248.

Windtree Therapeutics Inc Daily On-Balance Volume (OBV) ChartWindtree Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Windtree Therapeutics Inc. The current mfi is 49.68.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Windtree Therapeutics Inc Daily Money Flow Index (MFI) ChartWindtree Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Windtree Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Windtree Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Windtree Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.365
Ma 20Greater thanMa 500.370
Ma 50Greater thanMa 1000.384
Ma 100Greater thanMa 2000.604
OpenGreater thanClose0.360
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Windtree Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Windtree Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Windtree Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Windtree Therapeutics Inc

I send you an email if I find something interesting about Windtree Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Windtree Therapeutics Inc.

Receive notifications about Windtree Therapeutics Inc in your mailbox!